Neoadjuvant tislelizumab plus chemotherapy followed by salvage surgery and adjuvant tislelizumab for recurrent head and neck squamous cell carcinoma after radiotherapy: A single-arm, phase II trial

被引：0
|
作者：
Wu, Wenjie
Wang, Lin
Zhang, Tong
Zhang, Jie
机构：
[1] Peking Univ, Sch & Hosp Stomatol, Beijing, Peoples R China
[2] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6070
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant Chemotherapy plus Tislelizumab Followed by Adjuvant Tislelizumab for Locoregionally Advanced Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
    Shiran, S.
    Huang, X.
    Wang, K.
    Wu, R.
    Wang, J.
    Zhang, Y.
    Qu, Y.
    Chen, X.
    Zhang, J.
    Luo, J.
    Yi, J.
    Zhou, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E791 - E791
  • [2] Tislelizumab plus chemotherapy as induction treatment followed by chemoradiotherapy or surgery in locally advanced hypopharyngeal squamous cell carcinoma: A single-arm, phase II trial
    Gui, Lin
    Liu, Shaoyan
    Wang, Xiaolei
    Zhang, Ye
    He, Xiaohui
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: A single-arm, phase II trial
    Wu, Wenjie
    Yao, Jie
    Zhang, Tong
    Zhang, Jie
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Neoadjuvant Chemoradiotherapy plus Sequential Tislelizumab Followed by Surgery for Esophageal Carcinoma (CRISEC study): A Prospective, Single-Arm, Phase II Trial
    Yang, J.
    Zhang, Z.
    Wu, B.
    Liu, C.
    Qin, Y.
    Wen, L.
    Wei, J.
    Xiao, G.
    Xing, S.
    Qu, Y.
    Huang, L.
    Wang, X.
    Wang, B.
    Zuo, Z.
    Can, F.
    Jiang, K.
    Yang, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E502 - E502
  • [5] Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial
    Yang, Jinsong
    Huang, Ai
    Yang, Kunyu
    Jiang, Ke
    BMC CANCER, 2023, 23 (01)
  • [6] Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial
    Jinsong Yang
    Ai Huang
    Kunyu Yang
    Ke Jiang
    BMC Cancer, 23
  • [7] Safety and efficacy of neoadjuvant therapy with tislelizumab plus chemotherapy for locally advanced head and neck squamous cell carcinoma: a single-arm, retrospective study
    Liang, Haifeng
    Liang, Wenting
    Tian, Jiawang
    Zheng, Shibei
    Su, Yangzhou
    Huang, Piao
    Chen, Renhui
    Guan, Zhong
    Cai, Qian
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (03)
  • [8] Neoadjuvant chemotherapy plus tislelizumab followed by concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A single-arm, phase II trial.
    Chen, Qiu-Yan
    Mai, Hai-Qiang
    Tang, Lin-Quan
    Luo, Meijuan
    Zhao, Chong
    Mo, Hao-Yuan
    Sun, Rui
    Luo, Dong-Hua
    Wang, Lin
    Guo, Shan-Shan
    Xie, Siyi
    Li, Su-Chen
    Liu, Sai-Lan
    Li, Xiao Yun
    Peng, Jing-Yun
    Qiu, Hui-Zhi
    Sun, Xue-Song
    Liu, LiTing
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Clinical/biomarker data for neoadjuvant tislelizumab (TIS) plus chemotherapy (Chemo) in resectable locally advanced head and neck squamous cell carcinoma (LA-HNSCC): A single-arm, phase II trial
    Li, Q.
    Cai, L.
    Kuang, D.
    Pan, C.
    Zhao, J.
    Huang, P.
    He, C.
    Xu, K.
    Liu, D.
    Long, G.
    Liu, Z.
    Hu, G.
    Lu, X.
    ANNALS OF ONCOLOGY, 2024, 35 : S621 - S622
  • [10] Neoadjuvant chemoradiotherapy plus sequential tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): A single-arm, bicentric, phase 2 trial
    Yang, Jinsong
    Liu, Cui
    Zuo, Zhigang
    Cao, Fengjun
    Zhang, Zhanjie
    Wu, Bian
    Qin, You
    Wen, Lu
    Wei, Jielin
    Xiao, Guangqin
    Xing, Shijie
    Qu, Yue
    Huang, Lei
    Wang, Xiaolin
    Wang, Buhai
    Yang, Kunyu
    Jiang, Ke
    RADIOTHERAPY AND ONCOLOGY, 2025, 206
12345